目录产品 » ALK hFc Chimera, Mouse
Manual
SDS
COAs

ALK hFc Chimera, Mouse

Anaplastic lymphoma kinase (ALK) is mostly known for its oncogenic role in several human cancers. Recent evidences clearly indicate new roles of ALK and its genetic aberrations (e.g. gene rearrangements and mutations) in immune evasion, innate and cell-mediated immunity. New ALK-related immunotherapy approaches are demonstrating both preclinical and clinical promises.
￥2800
Z05993-100

产品简介
Species Mouse
Protein Construction
ALK (Ser19-Cys692)_x000D_
Accession # P97793		 hFc
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 101.11 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 115-125 kDa based on Bis-Tris PAGE result.
Formulation Supplied as 0.22μm filtered solution in PBS, 10% Glycerol (pH 7.4).
Concentration Verified by one or more methods from 0.64mg/ml A280/Bioactivity/BCA/Bradford.
Storage & Stability This product remains stable for 6 months at -80°C or below. Avoid repeated freeze-thaw cycles.
返回

技术背景
Target Background Anaplastic lymphoma kinase (ALK) is mostly known for its oncogenic role in several human cancers. Recent evidences clearly indicate new roles of ALK and its genetic aberrations (e.g. gene rearrangements and mutations) in immune evasion, innate and cell-mediated immunity. New ALK-related immunotherapy approaches are demonstrating both preclinical and clinical promises.
Synonyms ALK tyrosine kinase receptor; Anaplastic lymphoma kinase; CD246;
返回

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.